|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
|
US4314081A
(en)
|
1974-01-10 |
1982-02-02 |
Eli Lilly And Company |
Arloxyphenylpropylamines
|
|
NL7503310A
(nl)
|
1975-03-20 |
1976-09-22 |
Philips Nv |
Verbindingen met antidepressieve werking.
|
|
US4576753A
(en)
|
1975-10-06 |
1986-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Azetidinone compounds and processes for preparation thereof
|
|
GB1526331A
(en)
|
1976-01-14 |
1978-09-27 |
Kefalas As |
Phthalanes
|
|
US4341698A
(en)
|
1979-06-21 |
1982-07-27 |
Richardson-Merrell Inc. |
Enkaphalin derivatives
|
|
US4536518A
(en)
|
1979-11-01 |
1985-08-20 |
Pfizer Inc. |
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
|
JPS6033439B2
(ja)
|
1980-03-07 |
1985-08-02 |
財団法人相模中央化学研究所 |
ジペプチドの製造方法
|
|
JPS56125361A
(en)
|
1980-03-07 |
1981-10-01 |
Sagami Chem Res Center |
Azetidinone compound
|
|
FR2508035A1
(fr)
|
1981-06-23 |
1982-12-24 |
Fabre Sa Pierre |
Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
|
|
US4761501A
(en)
|
1983-10-26 |
1988-08-02 |
American Home Products Corporation |
Substituted phenylacetamides
|
|
US4751299A
(en)
|
1983-11-18 |
1988-06-14 |
Takeda Chemical Industries, Ltd. |
Optically active β-lactams and method of their production
|
|
US4665171A
(en)
|
1985-07-17 |
1987-05-12 |
Harvard University |
Process and intermediates for β-lactam antibiotics
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4734498A
(en)
|
1986-07-10 |
1988-03-29 |
Eli Lilly And Company |
3β-succinimidoazetidinones as chiral intermediates
|
|
US4772694A
(en)
|
1986-07-24 |
1988-09-20 |
Eli Lilly And Company |
Chiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediates
|
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
|
US5011472A
(en)
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
|
US5627165A
(en)
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
|
WO1992005784A1
(en)
|
1990-10-02 |
1992-04-16 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
|
|
GB9204001D0
(en)
|
1992-02-25 |
1992-04-08 |
Jacobs Suchard Ag |
Process for producing reduced fat nuts
|
|
US5246943A
(en)
|
1992-05-19 |
1993-09-21 |
Warner-Lambert Company |
Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
|
|
AU4713293A
(en)
|
1992-07-13 |
1994-01-31 |
Merck Sharp & Dohme Limited |
Heterocyclic amide derivatives as tachykinin derivatives
|
|
CA2140640A1
(en)
|
1992-08-13 |
1994-03-03 |
David C. Horwell |
Tachykinin antagonists
|
|
FR2696178B1
(fr)
|
1992-09-30 |
1994-12-30 |
Sanofi Elf |
Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
|
|
WO1994026735A1
(en)
|
1993-05-06 |
1994-11-24 |
Merrell Dow Pharmaceuticals Inc. |
Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
|
|
US5512563A
(en)
|
1993-07-29 |
1996-04-30 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5759865A
(en)
|
1995-05-03 |
1998-06-02 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
|
GB9511694D0
(en)
|
1995-06-09 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Benzamide derivatives
|
|
US6204260B1
(en)
|
1996-02-23 |
2001-03-20 |
Eli Lilly And Company |
Non-peptidyl vasopressin V1a antagonists
|
|
IL133788A0
(en)
|
1997-07-30 |
2001-04-30 |
American Home Prod |
Tricyclic vasopressin agonists
|
|
US6403632B1
(en)
|
2000-03-01 |
2002-06-11 |
Bristol Myers Squibb Pharma Co |
Lactam metalloprotease inhibitors
|
|
BR9812772A
(pt)
|
1997-10-27 |
2000-10-10 |
Reddy Research Foundation |
"compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
|
|
WO2001012171A2
(en)
|
1999-08-16 |
2001-02-22 |
Revaax Pharmaceuticals, Llc |
Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
|
|
GB0019006D0
(en)
|
2000-08-04 |
2000-09-20 |
Astrazeneca Ab |
Novel compounds
|
|
AU2002342045C1
(en)
*
|
2001-10-12 |
2009-07-30 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin Vla antagonists
|
|
WO2003051314A2
(en)
|
2001-12-18 |
2003-06-26 |
Medallion Biomedical, Llc |
Antibiotic compounds
|
|
US7135479B2
(en)
|
2002-09-12 |
2006-11-14 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
|
|
GB0224919D0
(en)
|
2002-10-25 |
2002-12-04 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
WO2005035492A1
(en)
|
2003-10-03 |
2005-04-21 |
Serenix Pharmaceuticals, Llc. |
3-SUBSTITUTED β-LACTAMYL VASOPRESSIN V1A ANTAGONISTS
|
|
US7745630B2
(en)
|
2003-12-22 |
2010-06-29 |
Justin Stephen Bryans |
Triazolyl piperidine arginine vasopressin receptor modulators
|
|
EP1632494A1
(en)
|
2004-08-24 |
2006-03-08 |
Ferring B.V. |
Vasopressin v1a antagonists
|
|
EP1669776A1
(de)
|
2004-12-11 |
2006-06-14 |
Leica Geosystems AG |
Handhaltbares Vermessungsgerät und Vermessungsverfahren für ein solches Vermessungsgerät
|
|
FR2881744B1
(fr)
|
2005-02-09 |
2007-04-27 |
Sanofi Aventis Sa |
Derives de n-[(4,5-diphenyl-2-thienyl)methyl]amine, leur preparation et leur application en therapeutique
|
|
CN104922117A
(zh)
*
|
2005-03-22 |
2015-09-23 |
阿泽范药品公司 |
用于治疗月经前病症的β-内酰氨基链烷酸
|
|
EP1885713A1
(en)
*
|
2005-05-18 |
2008-02-13 |
Pfizer Limited |
1, 2, 4 -triazole derivatives as vasopressin antagonists
|
|
CA2615813C
(en)
*
|
2005-07-19 |
2015-12-15 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
|
|
WO2007109615A2
(en)
|
2006-03-21 |
2007-09-27 |
Azevan Pharmaceuticals, Inc. |
β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
|
|
WO2008034032A2
(en)
|
2006-09-14 |
2008-03-20 |
Azevan Pharmaceuticals, Inc. |
Beta-lactam cannabinoid receptor modulators
|
|
EP2076517A1
(en)
|
2006-09-22 |
2009-07-08 |
Janssen Pharmaceutica N.V. |
Spiro benzazepines as vasopressin antagonists
|
|
JP5450108B2
(ja)
|
2007-03-23 |
2014-03-26 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化剤としての２−アミノピリジン類似体
|
|
US20090182011A1
(en)
*
|
2008-01-16 |
2009-07-16 |
University Of Illinois Chicago |
Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression
|
|
FR2927625B1
(fr)
|
2008-02-19 |
2010-03-12 |
Sanofi Aventis |
Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
|
|
FR2930249B1
(fr)
|
2008-04-21 |
2010-05-14 |
Sanofi Aventis |
Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
|
|
AU2011272738B2
(en)
|
2010-07-01 |
2015-08-20 |
Azevan Pharmaceuticals, Inc. |
Methods for treating post traumatic stress disorder
|
|
US20150376198A1
(en)
|
2013-02-18 |
2015-12-31 |
The Scripps Research Institute |
Modulators of vasopressin receptors with therapeutic potential
|
|
BR112016022575A2
(pt)
|
2014-03-28 |
2017-08-15 |
Azevan Pharmaceuticals Inc |
Composições e métodos para o tratamento de doenças neurodegenerativas
|
|
KR102790657B1
(ko)
|
2017-09-15 |
2025-04-02 |
아제반 파마슈티칼스, 인코퍼레이티드 |
뇌 손상을 치료하기 위한 조성물 및 방법
|